Marta Riol-Ruiz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.
Journal: Frontiers in microbiology
Published: June 13, 2025
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
Journal: Journal of virology
Published: January 31, 2023
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells.
Journal: Communications biology
Published: January 09, 2023
Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections.
Journal: Frontiers in immunology
Published: August 25, 2022
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Journal: Frontiers in immunology
Published: July 22, 2022
T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.
Journal: Frontiers in immunology
Published: April 25, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Journal: Nature medicine
Published: November 03, 2021
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
Journal: EBioMedicine
Published: October 29, 2021
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Journal: Microbiome
Published: June 18, 2021
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 07, 2020
Last Updated: 09/26/2026